240 related articles for article (PubMed ID: 22995428)
1. Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development.
Cook AD; Pobjoy J; Steidl S; Dürr M; Braine EL; Turner AL; Lacey DC; Hamilton JA
Arthritis Res Ther; 2012 Sep; 14(5):R199. PubMed ID: 22995428
[TBL] [Abstract][Full Text] [Related]
2. Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice.
Lee KM; Prasad V; Achuthan A; Fleetwood AJ; Hamilton JA; Cook AD
Osteoarthritis Cartilage; 2020 Apr; 28(4):486-491. PubMed ID: 32028021
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain.
Cook AD; Pobjoy J; Sarros S; Steidl S; Dürr M; Lacey DC; Hamilton JA
Ann Rheum Dis; 2013 Feb; 72(2):265-70. PubMed ID: 22833372
[TBL] [Abstract][Full Text] [Related]
4. TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.
Cook AD; Lee MC; Saleh R; Khiew HW; Christensen AD; Achuthan A; Fleetwood AJ; Lacey DC; Smith JE; Förster I; Hamilton JA
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563337
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
[TBL] [Abstract][Full Text] [Related]
6. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
7. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
[TBL] [Abstract][Full Text] [Related]
8. Expression of granulocyte macrophage-colony stimulating factor and its receptor in the synovium of osteoarthritis patients is negatively correlated with pain.
van Helvoort EM; Eijkelkamp N; Lafeber FPJG; Mastbergen SC
Rheumatology (Oxford); 2020 Nov; 59(11):3452-3457. PubMed ID: 32365364
[TBL] [Abstract][Full Text] [Related]
9. CCL17 blockade as a therapy for osteoarthritis pain and disease.
Lee MC; Saleh R; Achuthan A; Fleetwood AJ; Förster I; Hamilton JA; Cook AD
Arthritis Res Ther; 2018 Apr; 20(1):62. PubMed ID: 29622035
[TBL] [Abstract][Full Text] [Related]
10. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor.
Yang YH; Hamilton JA
Arthritis Rheum; 2001 Jan; 44(1):111-9. PubMed ID: 11212148
[TBL] [Abstract][Full Text] [Related]
11. Role of GM-CSF in a mouse model of experimental autoimmune prostatitis.
Liu Y; Li Y; Liu Q; Wu Z; Cui J; Zhu K; Zhao H; Zhou C; Shi B
Am J Physiol Renal Physiol; 2019 Jul; 317(7):F23-F29. PubMed ID: 30943070
[TBL] [Abstract][Full Text] [Related]
12. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
[TBL] [Abstract][Full Text] [Related]
13. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.
Cook AD; Turner AL; Braine EL; Pobjoy J; Lenzo JC; Hamilton JA
Arthritis Rheum; 2011 Aug; 63(8):2340-51. PubMed ID: 21809323
[TBL] [Abstract][Full Text] [Related]
14. The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice.
Shin H; Prasad V; Lupancu T; Malik S; Achuthan A; Biondo M; Kingwell BA; Thiem M; Gottschalk M; Weighardt H; Förster I; de Steiger R; Hamilton JA; Lee KM
Osteoarthritis Cartilage; 2023 Oct; 31(10):1327-1341. PubMed ID: 37225052
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF in murine psoriasiform dermatitis: Redundant and pathogenic roles uncovered by antibody-induced neutralization and genetic deficiency.
Scholz T; Weigert A; Brüne B; Sadik CD; Böhm B; Burkhardt H
PLoS One; 2017; 12(8):e0182646. PubMed ID: 28777803
[TBL] [Abstract][Full Text] [Related]
16. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury.
Kitching AR; Ru Huang X; Turner AL; Tipping PG; Dunn AR; Holdsworth SR
J Am Soc Nephrol; 2002 Feb; 13(2):350-358. PubMed ID: 11805162
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice.
Campbell IK; Bendele A; Smith DA; Hamilton JA
Ann Rheum Dis; 1997 Jun; 56(6):364-8. PubMed ID: 9227165
[TBL] [Abstract][Full Text] [Related]
18. Multi-response model for rheumatoid arthritis based on delay differential equations in collagen-induced arthritic mice treated with an anti-GM-CSF antibody.
Koch G; Wagner T; Plater-Zyberk C; Lahu G; Schropp J
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):55-65. PubMed ID: 22193331
[TBL] [Abstract][Full Text] [Related]
19. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential.
Hamilton JA
Expert Rev Clin Immunol; 2015 Apr; 11(4):457-65. PubMed ID: 25748625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
